Add BrightSurf on Google Email

Late-breaking clinical trials

Researchers tested bosentan for idiopathic pulmonary fibrosis and found no significant improvements. In contrast, two-day neuromuscular blocking agent therapy improved survival in patients with severe acute respiratory distress syndrome (ARDS). Oral iloprost showed promise in preventing lung cancer among former smokers.

PROTECT study

The PROTECT trial found that rolofylline had no significant effect on primary or secondary end-points in patients with acute heart failure, including dyspnea improvement and persistent renal impairment. The study did show an increased risk of neurological events in rolofylline-treated patients.

Results from the PRAGUE-7 study

The PRAGUE-7 study, a randomized trial, investigated the effect of routine upfront administration of abciximab on outcomes in acute myocardial infarction (AMI) patients complicated by cardiogenic shock. The study found no significant benefit from this approach, with similar results seen between groups receiving standard or selective ab...

Lung volume reduction surgery shown to prolong and improve life for some emphysema patients

Patients who underwent lung reduction surgery showed a significant survival benefit compared to medical treatment, with an average time until a 'composite event' of two years. The procedure also improved quality of life for at least five years post-operative period, especially in patients with upper-lobe-predominant emphysema.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJul 23, 2009

Review identifies dietary factors associated with heart disease risk

A review of 146 prospective cohort studies and 43 randomized controlled trials found strong evidence for a causal relationship between protective dietary factors such as vegetable, nut, and monounsaturated fatty acid intake and lower heart disease risk. The Mediterranean diet was significantly associated with coronary heart disease.

SourceJAMA Network·JournalArchives of Internal Medicine·DateApr 13, 2009

Coronary artery bypass surgery could be better than catheter and balloon intervention for diabetics and patients aged 65-75 years

A recent study comparing coronary artery bypass graft surgery (CABG) with catheter/balloon/stent percutaneous intervention (PCI) found that CABG may be a better option for patients with diabetes and those aged 65-75 years. The research, involving 7812 patients, revealed lower mortality rates in these subgroups.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 19, 2009

ARDS mortality is unchanged since 1994

Mortality rates for acute respiratory distress syndrome (ARDS) have remained relatively stable since 1994, with a benchmark mortality of 40-45% according to a comprehensive review of major studies. The findings highlight the need for effective therapeutic interventions for this highly lethal syndrome.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 23, 2009

Fatty liver disease medication may have no effect

A new trial found that orlistat, a common fat absorption inhibitor, does not help patients with fatty liver disease lose weight or improve liver enzymes. However, moderate weight loss was associated with significant improvements in liver symptoms.

SourceWiley·JournalHepatology·DateJan 13, 2009

Removing user fees does not improve health outcomes in Ghana

A new study published in PLoS Medicine found that removing user fees for primary health care changed health utilization behavior but did not improve health outcomes among children under 5 years old in Ghana. The study's findings challenge the assumption that free healthcare leads to better health outcomes.

SourcePLOS·JournalPLOS Medicine·DateJan 5, 2009

Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial

A randomized controlled trial found that women taking vitamin C, E, or beta carotene had a similar risk of cancer as those not taking the supplements. Antioxidant supplements were previously thought to lower cancer risk due to high fruit and vegetable intake, but this study contradicts those findings.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 30, 2008

Gingko biloba does not appear to prevent dementia, Alzheimer's disease

A randomized, placebo-controlled clinical trial found no significant difference in the rate of dementia among participants using Ginkgo biloba or a placebo. The study, which included over 1,500 elderly volunteers, also showed that Ginkgo biloba had no effect on the progression to dementia in individuals with mild cognitive impairment.

SourceJAMA Network·JournalJournal of the American Medical Association·DateNov 18, 2008

Stress urinary incontinence paper retracted

A paper on stress urinary incontinence treatment has been retracted from publication after an investigation found critical deficiencies in patient consent and document authenticity. Senior author Georg Bartsch denied involvement, but the study's flaws have raised concerns about research integrity.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 4, 2008